Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registry - Rivaroxaban cohort
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2016
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms JACRE-R
- Sponsors Bayer Yakuhin
- 25 Oct 2016 Results assessing safety and efficacy from Rivaroxaban cohort (JACRE-R) and Warfarin cohort (JACRE-W) studies published in the Circulation Journal.
- 09 Sep 2016 Status changed from recruiting to completed.
- 12 Aug 2014 New trial record